S100A9 is a calcium binding protein that is said to have implications in cancer associated with inflammation, circM1D1 expression is highly upregulated in prostate cancer cells treated with MDSC exosomes and miR-506-3p was found to be an inhibitor of CRC progression through EZH2-targeted mechanisms (65–67). Here, S100A9 is linked to prostate cancer.